Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged Antibiotics for Relapsing Peritonitis Prevention in PD
NCT02593201Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin, ceftazidime in peritonitis, sponsored by The Chinese University of Hong Kong. Started Feb 2016; status: completed.
02
Drugs
cefazolinceftazidime
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT02593201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02593201.